JW Lifescience Corporation (234080.KS)
KRW 11520.0
(-0.78%)
KRW 11520.0
(-0.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 206.86 Billion | 188.93 Billion | 169.81 Billion | 183.52 Billion | 170.22 Billion | 155.23 Billion |
| Cost of Revenue | 155.53 Billion | 140.81 Billion | 120.65 Billion | 124.02 Billion | 121.61 Billion | 115.71 Billion |
| Gross Profit | 51.32 Billion | 48.12 Billion | 49.15 Billion | 59.49 Billion | 48.6 Billion | 39.51 Billion |
| Operating Expenses | 20.26 Billion | 21.03 Billion | 20.74 Billion | 20.04 Billion | 18.85 Billion | 15.97 Billion |
| Selling, General and Administrative Expenses | 15.1 Billion | 8.76 Billion | 8.29 Billion | 7.6 Billion | 8.08 Billion | 7.39 Billion |
| Research and Development Expenses | 5.16 Billion | 5.73 Billion | 6.24 Billion | 5.19 Billion | 3.58 Billion | 1.24 Billion |
| Other Expenses | - | 6.53 Billion | 6.2 Billion | 7.24 Billion | 7.18 Billion | 384.6 Million |
| Cost and Expenses | 174.76 Billion | 161.84 Billion | 141.4 Billion | 144.07 Billion | 140.47 Billion | 131.68 Billion |
| Operating Income | 32.09 Billion | 27.08 Billion | 28.41 Billion | 39.45 Billion | 29.74 Billion | 23.54 Billion |
| Interest Expense | 2.69 Billion | 3.09 Billion | 1.28 Billion | 2.6 Billion | 1.72 Billion | 2.25 Billion |
| Income Tax Expense | 5.56 Billion | 5.82 Billion | 5.37 Billion | 5.44 Billion | 6.39 Billion | 5.48 Billion |
| Earnings before Tax | 32.62 Billion | 20.78 Billion | 18.28 Billion | 22.74 Billion | 28.33 Billion | 21.31 Billion |
| Net Income | 28.14 Billion | 14.96 Billion | 12.91 Billion | 17.3 Billion | 21.93 Billion | 15.82 Billion |
| Earnings Per Share Basic | 1817.55 | 966.21 | 828.84 | 1092.55 | 1385.48 | 999.14 |
| Earnings Per Share Diluted | 1817.55 | 966.21 | 828.84 | 1092.55 | 1385.48 | 999.00 |
| Weighted Average Shares Outstanding | 15.48 Million | 15.48 Million | 15.58 Million | 15.83 Million | 15.83 Million | 15.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.48 Million | 15.48 Million | 15.58 Million | 15.83 Million | 15.83 Million | 15.83 Million |
| Gross Margin | 0.25 | 0.25 | 0.29 | 0.32 | 0.29 | 0.25 |
| EBIT Margin | 0.25 | 0.21 | 0.22 | 0.25 | 0.25 | 0.23 |
| Profit Margin | 0.14 | 0.08 | 0.08 | 0.09 | 0.13 | 0.10 |
| EBITDA | 50.82 Billion | 43.72 Billion | 37.56 Billion | 37.56 Billion | 41.65 Billion | 34.64 Billion |
| Earnings Before Tax Margin | 0.16 | 0.14 | 0.17 | 0.21 | 0.17 | 0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 54.39 Billion | 55.33 Billion | 53.63 Billion | 206.86 Billion | 51.14 Billion | 52.08 Billion |
| Cost of Revenue | 40.5 Billion | 41.23 Billion | 40.01 Billion | 155.53 Billion | 39.24 Billion | 38.97 Billion |
| Gross Profit | 13.88 Billion | 14.09 Billion | 13.61 Billion | 51.32 Billion | 11.89 Billion | 13.11 Billion |
| Operating Expenses | 5.5 Billion | 5.49 Billion | 5.63 Billion | 20.46 Billion | 5.65 Billion | -5.33 Billion |
| Selling, General and Administrative Expenses | 4.29 Billion | 4.38 Billion | 3.87 Billion | - | 5.65 Billion | 5.33 Billion |
| Research and Development Expenses | 1.18 Billion | 958.47 Million | 1.73 Billion | - | 1.35 Billion | 1.02 Billion |
| Other Expenses | -29.16 Million | -151.09 Million | -31.69 Million | -161.56 Million | 62.31 Million | -10.66 Billion |
| Cost and Expenses | 46.01 Billion | 46.73 Billion | 45.65 Billion | 175.99 Billion | 44.9 Billion | 38.97 Billion |
| Operating Income | 8.38 Billion | 8.6 Billion | 7.98 Billion | 30.86 Billion | 6.23 Billion | 7.78 Billion |
| Interest Expense | - | 494.84 Million | 604.65 Million | 2.69 Billion | 623.14 Million | 715.28 Million |
| Income Tax Expense | 723.75 Million | 2.53 Billion | 898.62 Million | 5.56 Billion | 1.29 Billion | 1.49 Billion |
| Earnings before Tax | 7.99 Billion | 8.33 Billion | 12.07 Billion | 32.62 Billion | 5.84 Billion | 7.16 Billion |
| Net Income | 6.65 Billion | 5.13 Billion | 10.26 Billion | 28.14 Billion | 4.55 Billion | 5.66 Billion |
| Earnings Per Share Basic | 429.91 | 331.49 | 662.90 | - | 294.11 | 365.80 |
| Earnings Per Share Diluted | 429.91 | 331.49 | 662.90 | - | 294.11 | 365.80 |
| Weighted Average Shares Outstanding | 15.48 Million | 15.48 Million | 15.48 Million | 15.48 Million | 15.48 Million | 15.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.48 Million | 15.48 Million | 15.48 Million | 15.48 Million | 15.48 Million | 15.48 Million |
| Gross Margin | 0.26 | 0.25 | 0.25 | 0.25 | 0.23 | 0.25 |
| EBIT Margin | 0.23 | 0.23 | 0.22 | - | 0.20 | 0.25 |
| Profit Margin | 0.12 | 0.09 | 0.19 | 0.14 | 0.09 | 0.11 |
| EBITDA | 12.29 Billion | 12.51 Billion | 11.9 Billion | - | 10.14 Billion | 13.11 Billion |
| Earnings Before Tax Margin | 0.15 | 0.16 | 0.15 | 0.15 | 0.12 | 0.15 |
300976
004100
1198
LDX
600289
301135